首页> 外文期刊>British Journal of Cancer >DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease
【24h】

DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease

机译:DNA倍性和S期在原发性恶性黑色素瘤中作为III期疾病的预后因素

获取原文
获取外文期刊封面目录资料

摘要

In 82 patients with stage III malignant melanoma, the primary tumours were investigated by DNA flow cytometry. The tumours were classified as DNA diploid (n = 36), tetraploid (n = 11) and aneuploid (n = 35). By univariate analysis a significant correlation with post-recurrence survival was found for time to first metastasis, DNA-ploidy and S-phase fraction. By multivariate analysis, significant prognostic variables were found to be the time to first metastasis (P = 0.006), and ploidy (P = 0.011). Patients with diploid melanomas and a long recurrence-free interval had a median post-recurrence survival time of 45 months compared to 18 months in patients with DNA aneuploid tumours and an early recurrence. The S-phase could be estimated in 47 primary melanomas and was found to be a significant prognostic variable (P = 0.017). The median survival was 45 months for patients with melanomas with a S-phase fraction below 5%, and 19 months for melanomas with S-phase above 10%. The prognostic value of the S-phase remained significant even after adjustment for recurrence-free interval and DNA ploidy.
机译:在82例III期恶性黑色素瘤患者中,通过DNA流式细胞术研究了原发肿瘤。肿瘤分为DNA二倍体(n = 36),四倍体(n = 11)和非整倍体(n = 35)。通过单变量分析,发现首次转移时间,DNA倍性和S期分数与复发后生存率显着相关。通过多变量分析,发现重要的预后变量是首次转移的时间(P = 0.006)和倍性(P = 0.011)。二倍体黑素瘤患者和无复发间隔长的患者,其复发后中位生存时间为45个月,而DNA非整倍体肿瘤和早期复发患者的中位复发后生存时间为18个月。 S期可在47例原发性黑色素瘤中进行评估,并被发现是一个重要的预后变量(P = 0.017)。 S期分数低于5%的黑色素瘤患者的中位生存期为45个月,S期分数高于10%的黑色素瘤患者的中位生存期为19个月。即使调整无复发间隔和DNA倍性,S期的预后价值仍然很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号